"Androgens" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Compounds that interact with ANDROGEN RECEPTORS in target tissues to bring about the effects similar to those of TESTOSTERONE. Depending on the target tissues, androgenic effects can be on SEX DIFFERENTIATION; male reproductive organs, SPERMATOGENESIS; secondary male SEX CHARACTERISTICS; LIBIDO; development of muscle mass, strength, and power.
| Descriptor ID |
D000728
|
| MeSH Number(s) |
D27.505.696.399.472.161
|
| Concept/Terms |
Androgens- Androgens
- Androgenic Compounds
- Compounds, Androgenic
- Androgen Receptor Agonists
- Agonists, Androgen Receptor
- Receptor Agonists, Androgen
- Androgenic Agents
- Agents, Androgenic
Androgen Effect- Androgen Effect
- Effect, Androgen
- Androgen Effects
- Effects, Androgen
|
Below are MeSH descriptors whose meaning is more general than "Androgens".
Below are MeSH descriptors whose meaning is more specific than "Androgens".
This graph shows the total number of publications written about "Androgens" by people in this website by year, and whether "Androgens" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 1 | 1 |
| 1996 | 2 | 0 | 2 |
| 1999 | 1 | 1 | 2 |
| 2000 | 0 | 1 | 1 |
| 2002 | 1 | 0 | 1 |
| 2003 | 1 | 0 | 1 |
| 2004 | 1 | 1 | 2 |
| 2005 | 3 | 1 | 4 |
| 2006 | 3 | 1 | 4 |
| 2007 | 1 | 1 | 2 |
| 2008 | 3 | 1 | 4 |
| 2009 | 2 | 0 | 2 |
| 2010 | 2 | 0 | 2 |
| 2011 | 1 | 0 | 1 |
| 2012 | 1 | 1 | 2 |
| 2013 | 1 | 1 | 2 |
| 2014 | 0 | 1 | 1 |
| 2016 | 1 | 0 | 1 |
| 2019 | 1 | 0 | 1 |
| 2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Androgens" by people in Profiles.
-
Auchus RJ, Courtillot C, Dobs A, El-Maouche D, Falhammar H, Lacroix A, Farrar M, O'Donoghue C, Anatchkova M, Cutts K, Taylor N, Yonan C, Lamotte M, Touraine P. Treatment patterns and unmet needs in adults with classic congenital adrenal hyperplasia: A modified Delphi consensus study. Front Endocrinol (Lausanne). 2022; 13:1005963.
-
Lau HD, Clark M. Metastatic squamous cell carcinoma transformed from prostatic adenocarcinoma following androgen deprivation therapy: A case report with clinicopathologic and molecular findings. Diagn Cytopathol. 2020 Dec; 48(12):E14-E17.
-
Fan EM, Gordner C, Luty J. Venous Thromboembolism in a Transgender Adolescent on Testosterone Therapy: A Case Report and Literature Review. J Pediatr Hematol Oncol. 2020 07; 42(5):e352-e354.
-
Jasuja GK, Engle RL, Skolnik A, Rose AJ, Male A, Reisman JI, Bokhour BG. Understanding the Context of High- and Low-Testosterone Prescribing Facilities in the Veterans Health Administration (VHA): a Qualitative Study. J Gen Intern Med. 2019 11; 34(11):2467-2474.
-
Rotker KL, Alavian M, Nelson B, Baird GL, Miner MM, Sigman M, Hwang K. Association of subcutaneous testosterone pellet therapy with developing secondary polycythemia. Asian J Androl. 2018 Mar-Apr; 20(2):195-199.
-
Onasanya O, Iyer G, Lucas E, Lin D, Singh S, Alexander GC. Association between exogenous testosterone and cardiovascular events: an overview of systematic reviews. Lancet Diabetes Endocrinol. 2016 11; 4(11):943-956.
-
Polotsky AJ, Allshouse AA, Crawford SL, Harlow SD, Khalil N, Kazlauskaite R, Santoro N, Legro RS. Hyperandrogenic oligomenorrhea and metabolic risks across menopausal transition. J Clin Endocrinol Metab. 2014 Jun; 99(6):2120-7.
-
Lasley BL, Crawford SL, McConnell DS. Ovarian adrenal interactions during the menopausal transition. Minerva Ginecol. 2013 Dec; 65(6):641-51.
-
Yurkovetskiy L, Burrows M, Khan AA, Graham L, Volchkov P, Becker L, Antonopoulos D, Umesaki Y, Chervonsky AV. Gender bias in autoimmunity is influenced by microbiota. Immunity. 2013 Aug 22; 39(2):400-12.
-
Lai JJ, Chang P, Lai KP, Chen L, Chang C. The role of androgen and androgen receptor in skin-related disorders. Arch Dermatol Res. 2012 Sep; 304(7):499-510.